{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:28:48Z","timestamp":1790224128616,"version":"4.1.0"},"reference-count":200,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004784","name":"Novartis Foundation for Medical-Biological Research","doi-asserted-by":"publisher","award":["24C263"],"award-info":[{"award-number":["24C263"]}],"id":[{"id":"10.13039\/501100004784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness","doi-asserted-by":"publisher","award":["PPA-0923-0865-HUJ"],"award-info":[{"award-number":["PPA-0923-0865-HUJ"]}],"id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness","doi-asserted-by":"publisher","award":["TA-GT-0424-0874-FAA-TRAP"],"award-info":[{"award-number":["TA-GT-0424-0874-FAA-TRAP"]}],"id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.mam.2025.101424","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T20:21:14Z","timestamp":1763670074000},"page":"101424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Precision gene therapy: Tailoring rAAV-mediated gene therapies for inherited retinal dystrophies (IRDs)"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5350-5112","authenticated-orcid":false,"given":"F\u00e1bio","family":"Duarte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvan","family":"Arsenijevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mam.2025.101424_bib1","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.ymthe.2005.08.008","article-title":"Long-term restoration of rod and cone vision by single dose rAAV-Mediated gene transfer to the retina in a canine model of childhood blindness","volume":"12","author":"Acland","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mam.2025.101424_bib2","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1016\/j.ymthe.2021.03.021","article-title":"Gene therapy reforms photoreceptor structure and restores vision in NPHP5-associated Leber congenital amaurosis","volume":"29","author":"Aguirre","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mam.2025.101424_bib3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1167\/iovs.03-0804","article-title":"Transgenic mice expressing cre-recombinase specifically in M- or S-Cone photoreceptors","volume":"45","author":"Akimoto","year":"2004","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2025.101424_bib4","doi-asserted-by":"crossref","first-page":"11372","DOI":"10.1128\/JVI.01327-07","article-title":"Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors","volume":"81","author":"Allocca","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.mam.2025.101424_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/hmg\/dds398","article-title":"Loss of CRB2 in the mouse retina mimics human retinitis pigmentosa due to mutations in the CRB1 gene","volume":"22","author":"Alves","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mam.2025.101424_bib6","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR\u2013cas nucleases, base editors, transposases and prime","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.mam.2025.101424_bib7","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s44321-024-00053-x","article-title":"Fine-tuning FAM161A gene augmentation therapy to restore retinal function","volume":"16","author":"Arsenijevic","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.mam.2025.101424_bib8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.omtn.2019.01.012","article-title":"Suppression of choroidal neovascularization by AAV-based dual-acting antiangiogenic gene therapy","volume":"16","author":"Askou","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.mam.2025.101424_bib9","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa1414221","article-title":"Long-term effect of gene therapy on Leber's congenital amaurosis","volume":"372","author":"Bainbridge","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mam.2025.101424_bib10","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","article-title":"Effect of gene therapy on visual function in Leber's congenital amaurosis","volume":"358","author":"Bainbridge","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mam.2025.101424_bib11","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ajhg.2010.07.022","article-title":"Homozygosity mapping reveals null mutations in FAM161A as a cause of autosomal-recessive retinitis pigmentosa","volume":"87","author":"Bandah-Rozenfeld","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mam.2025.101424_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1092913","article-title":"Programmable RNA editing with endogenous ADAR enzymes \u2013 a feasible option for the treatment of inherited retinal disease?","volume":"16","author":"Bellingrath","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.mam.2025.101424_bib13","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/gt.2010.56","article-title":"RAAV2\/5 gene-targeting to rods: dose-dependent efficiency and complications associated with different promoters","volume":"17","author":"Beltran","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.mam.2025.101424_bib14","doi-asserted-by":"crossref","first-page":"E5844","DOI":"10.1073\/pnas.1509914112","article-title":"Successful arrest of photoreceptor and vision loss expands the therapeutic window of retinal gene therapy to later stages of disease","volume":"112","author":"Beltran","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mam.2025.101424_bib15","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1073\/pnas.1118847109","article-title":"Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosa","volume":"109","author":"Beltran","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mam.2025.101424_bib16","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1371\/journal.pmed.0030347","article-title":"Lentiviral gene transfer of Rpe65 rescues survival and function of cones in a mouse model of leber congenital amaurosis","volume":"3","author":"Bemelmans","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.mam.2025.101424_bib200","first-page":"1","article-title":"Retinal Viral Gene Therapy: Impact of Route of Administration on Serious Adverse Events - A Systematic Review","author":"Berger","year":"2025","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.mam.2025.101424_bib17","first-page":"1","article-title":"H105A peptide eye drops promote photoreceptor survival in murine and human models of retinal degeneration. Commun","volume":"5","author":"Bernardo-Col\u00f3n","year":"2025","journal-title":"Med"},{"key":"10.1016\/j.mam.2025.101424_bib18","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/s41467-019-09124-x","article-title":"Restoration of high-sensitivity and adapting vision with a cone opsin","volume":"10","author":"Berry","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2025.101424_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba5614","article-title":"A gene therapy for inherited blindness using dCas9-VPR-mediated transcriptional activation","volume":"6","author":"B\u00f6hm","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mam.2025.101424_bib20","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1089\/hum.2012.125","article-title":"The human rhodopsin kinase promoter in an AAV5 vector confers rod- and cone-specific expression in the primate retina","volume":"23","author":"Boye","year":"2012","journal-title":"Human Gene Therap."},{"key":"10.1016\/j.mam.2025.101424_bib21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/jgm.516","article-title":"Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle","volume":"6","author":"Brooks","year":"2004","journal-title":"J. Gene Med."},{"key":"10.1016\/j.mam.2025.101424_bib22","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ymthe.2006.05.019","article-title":"In contrast to AAV-mediated cntf expression, AAV-mediated gdnf expression enhances gene replacement therapy in rodent models of retinal degeneration","volume":"14","author":"Buch","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mam.2025.101424_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100915","article-title":"Immune responses to retinal gene therapy using adeno-associated viral vectors \u2013 implications for treatment success and safety","volume":"83","author":"Bucher","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.mam.2025.101424_bib24","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.3390\/ijms21124197","article-title":"Recombinant adeno-associated viral vectors (rAAV)-Vector elements in ocular gene therapy clinical trials and transgene expression and bioactivity assays","volume":"21","author":"Buck","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2025.101424_bib25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1172\/JCI65654","article-title":"Viral-mediated RdCVF and RdCVFL expression protects cone and rod photoreceptors in retinal degeneration","volume":"125","author":"Byrne","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.mam.2025.101424_bib26","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.135112","article-title":"In vivo\u2013directed evolution of adeno-associated virus in the primate retina","volume":"5","author":"Byrne","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.mam.2025.101424_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023782","article-title":"Retinal degeneration progression changes lentiviral vector cell targeting in the retina","volume":"6","author":"Calame","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2025.101424_bib28","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1093\/hmg\/ddr218","article-title":"Long-term and age-dependent restoration of visual function in a mouse model of CNGB3-associated achromatopsia following gene therapy","volume":"20","author":"Carvalho","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mam.2025.101424_bib29","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.cub.2015.07.029","article-title":"Restoration of vision with ectopic expression of human rod opsin","volume":"25","author":"Cehajic-Kapetanovic","year":"2015","journal-title":"Curr. Biol."},{"key":"10.1016\/j.mam.2025.101424_bib30","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/j.ymthe.2017.07.011","article-title":"A new promoter allows optogenetic vision restoration with enhanced sensitivity in macaque retina","volume":"25","author":"Chaffiol","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mam.2025.101424_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.visres.2023.108257","article-title":"Advancements in pre-clinical development of gene editing-based therapies to treat inherited retinal diseases","volume":"209","author":"Chirco","year":"2023","journal-title":"Vis. Res."},{"key":"10.1016\/j.mam.2025.101424_bib32","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1038\/s41467-022-29490-3","article-title":"In vivo base editing rescues cone photoreceptors in a mouse model of early-onset inherited retinal degeneration","volume":"13","author":"Choi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2025.101424_bib33","doi-asserted-by":"crossref","first-page":"15022","DOI":"10.1038\/mtm.2015.22","article-title":"AAV-mediated RLBP1 gene therapy improves the rate of dark adaptation in Rlbp1 knockout mice","volume":"2","author":"Choi","year":"2015","journal-title":"Mol. Ther., Methods Clin. Dev."},{"key":"10.1016\/j.mam.2025.101424_bib34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41591-018-0295-0","article-title":"Effect of an intravitreal antisense oligonucleotide on vision in Leber congenital amaurosis due to a photoreceptor cilium defect","volume":"25","author":"Cideciyan","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.mam.2025.101424_bib35","doi-asserted-by":"crossref","first-page":"E8547","DOI":"10.1073\/pnas.1805055115","article-title":"Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vector","volume":"115","author":"Cideciyan","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mam.2025.101424_bib36","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/gt.2014.8","article-title":"Efficient gene delivery to the cone-enriched pig retina by dual AAV vectors","volume":"21","author":"Colella","year":"2014","journal-title":"Gene Ther."},{"key":"10.1016\/j.mam.2025.101424_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/humc.2013.037","article-title":"Preclinical potency and safety studies of an AAV2-Mediated gene therapy vector for the treatment of MERTK associated retinitis pigmentosa","volume":"24","author":"Conlon","year":"2013","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.mam.2025.101424_bib38","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.15252\/emmm.201404077","article-title":"Efficient transduction and optogenetic stimulation of retinal bipolar cells by a synthetic adeno\u2010associated virus capsid and promoter","volume":"6","author":"Cronin","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.mam.2025.101424_bib39","article-title":"Therapeutic in vivo gene editing achieved by a hypercompact CRISPR-Cas12f1 system delivered with all-in-one adeno-associated virus","volume":"11","author":"Cui","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.mam.2025.101424_bib40","doi-asserted-by":"crossref","first-page":"15003","DOI":"10.1038\/mtm.2015.3","article-title":"Nuclear expression of mitochondrial ND4 leads to the protein assembling in complex I and prevents optic atrophy and visual loss","volume":"2","author":"Cwerman-Thibault","year":"2015","journal-title":"Mol. Ther., Methods Clin. Dev."},{"key":"10.1016\/j.mam.2025.101424_bib41","series-title":"Advances in Experimental Medicine and Biology","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-3-031-27681-1_16","article-title":"Analysis of CRB1 pathogenic variants correctable with CRISPR base and prime editing","author":"da Costa","year":"2023"},{"key":"10.1016\/j.mam.2025.101424_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005708","article-title":"In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous","volume":"5","author":"Dalkara","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.mam.2025.101424_bib43","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/mt.2011.62","article-title":"AAV mediated GDNF secretion from retinal glia slows Down retinal degeneration in a rat model of retinitis pigmentosa","volume":"19","author":"Dalkara","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mam.2025.101424_bib44","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/IAE.0000000000003413","article-title":"Autosomal dominant m\u00fcller cell sheen dystrophy: clinical, histopathologic, and genetic assessment in an extended family with long Follow-Up","volume":"42","author":"Dalma-Weiszhausz","year":"2022","journal-title":"Retina"},{"key":"10.1016\/j.mam.2025.101424_bib45","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1016\/j.ymthe.2024.10.004","article-title":"Dual CRALBP isoforms unveiled: ipsc-derived retinal modeling and AAV2\/5-RLBP1 gene transfer raise considerations for effective therapy","volume":"32","author":"Damodar","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mam.2025.101424_bib46","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1093\/hmg\/ddae144","article-title":"Delivering large genes using adeno-associated virus and the CRE-lox DNA recombination system","volume":"33","author":"Datta","year":"2024","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mam.2025.101424_bib47","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1086\/321263","article-title":"Leber congenital amaurosis and retinitis pigmentosa with coats-like exudative vasculopathy are associated with mutations in the crumbs homologue 1 (CRB1) gene","volume":"69","author":"Den Hollander","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mam.2025.101424_bib48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1089\/jop.2024.0084","article-title":"Efficacy of intravitreal multi-characteristic opsin (MCO-010) optogenetic gene therapy in a mouse model of leber congenital amaurosis","volume":"40","author":"Dibas","year":"2024","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.mam.2025.101424_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/science.1258096","article-title":"The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.mam.2025.101424_bib50","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2416827121","article-title":"In vivo photoreceptor base editing ameliorates rhodopsin-E150K autosomal-recessive retinitis pigmentosa in mice","volume":"121","author":"Du","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mam.2025.101424_bib51","article-title":"12-Month safety and efficacy evaluation of HORA-PDE6B, a gene therapy targeting patients with retinitis pigmentosa due to biallelic PDE6B gene mutation","volume":"65","author":"Ducloyer","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2025.101424_bib52","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.omtn.2018.07.010","article-title":"Splice-modulating oligonucleotide QR-110 restores CEP290 mRNA and function in human c.2991+1655A>G LCA10 models","volume":"12","author":"Dulla","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.mam.2025.101424_bib53","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/j.ymthe.2021.04.024","article-title":"Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations","volume":"29","author":"Dulla","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mam.2025.101424_bib54","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1089\/hgtb.2013.212","article-title":"Dual adeno-associated virus vectors result in efficient in vitro and in vivo expression of an oversized gene, MYO7A","volume":"25","author":"Dyka","year":"2014","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.mam.2025.101424_bib55","doi-asserted-by":"crossref","first-page":"19064","DOI":"10.1074\/jbc.M309881200","article-title":"Analysis of the VMD2 promoter and implication of E-box binding factors in its regulation","volume":"279","author":"Esumi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mam.2025.101424_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2024.110223","article-title":"The vectors went in two-by-two: transduction efficiency and tolerability of dual and triple rAAV vector delivery following intravitreal injection for genome-editing applications","volume":"251","author":"Fehrman","year":"2025","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.mam.2025.101424_bib57","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.omtm.2023.02.002","article-title":"Efficacy, pharmacokinetics, and safety in the mouse and primate retina of dual AAV vectors for Usher syndrome type 1B","volume":"28","author":"Ferla","year":"2023","journal-title":"Mol. Ther., Methods Clin. Dev."},{"key":"10.1016\/j.mam.2025.101424_bib58","first-page":"200","article-title":"Comparison of CRISPR-Cas13b RNA base editing approaches for USH2A-associated inherited retinal degeneration. Commun","volume":"8","author":"Fry","year":"2025","journal-title":"Biol"},{"key":"10.1016\/j.mam.2025.101424_bib59","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1038\/s41467-025-57628-6","article-title":"In vivo prime editing rescues photoreceptor degeneration in nonsense mutant retinitis pigmentosa","volume":"16","author":"Fu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2025.101424_bib60","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.ymthe.2019.04.002","article-title":"Improved CoChR variants restore visual acuity and contrast sensitivity in a mouse model of blindness under ambient light conditions","volume":"27","author":"Ganjawala","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mam.2025.101424_bib61","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1128\/JVI.78.12.6381-6388.2004","article-title":"Clades of adeno-associated viruses are widely disseminated in human tissues","volume":"78","author":"Gao","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.mam.2025.101424_bib62","first-page":"2552","article-title":"In vitro and in vivo rescue of aberrant splicing in CEP290-associated LCA by antisense oligonucleotide delivery","volume":"25","author":"Garanto","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mam.2025.101424_bib63","doi-asserted-by":"crossref","first-page":"15041","DOI":"10.3390\/ijms232315041","article-title":"Optogenetic therapy for visual restoration","volume":"23","author":"Garc\u00eda-Ayuso","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2025.101424_bib64","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/mt.2015.121","article-title":"Optogenetic vision restoration using rhodopsin for enhanced sensitivity","volume":"23","author":"Gaub","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mam.2025.101424_bib65","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.mam.2025.101424_bib66","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s42003-020-01594-w","article-title":"Optogenetic therapy: high spatiotemporal resolution and pattern discrimination compatible with vision restoration in non-human primates","volume":"4","author":"Gauvain","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.mam.2025.101424_bib67","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1080\/14712598.2021.1856365","article-title":"RNA therapeutics for retinal diseases","volume":"21","author":"Gemayel","year":"2021","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.mam.2025.101424_bib68","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/gt.2016.66","article-title":"Development of an optimized AAV2\/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65","volume":"23","author":"Georgiadis","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.mam.2025.101424_bib69","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/hmg\/ddx438","article-title":"Cas9\/sgRNA selective targeting of the P23H rhodopsin mutant allele for treating retinitis pigmentosa by intravitreal AAV9.PHP.B-based delivery","volume":"27","author":"Giannelli","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mam.2025.101424_bib70","article-title":"RNA-based therapies in inherited retinal diseases","volume":"14","author":"Girach","year":"2022","journal-title":"Ther. Adv. Ophthalmol."},{"key":"10.1016\/j.mam.2025.101424_bib71","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13024-024-00777-x","article-title":"A novel AAV vector for gene therapy of RPE-related retinal degenerative diseases via intravitreal delivery","volume":"19","author":"Gong","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.mam.2025.101424_bib72","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature04791","article-title":"Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways","volume":"441","author":"Grimm","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.mam.2025.101424_bib73","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.tibs.2024.03.002","article-title":"Computationally guided AAV engineering for enhanced gene delivery","volume":"49","author":"Guo","year":"2024","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.mam.2025.101424_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108482","article-title":"RNA therapeutics in ophthalmology - translation to clinical trials","volume":"205","author":"Gupta","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.mam.2025.101424_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075666","article-title":"Recombinant AAV-mediated BEST1 transfer to the retinal pigment epithelium: analysis of serotype-dependent retinal effects","volume":"8","author":"Guziewicz","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2025.101424_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtm.2018.11.003","article-title":"Gene transfer with AAV9-PHP.B rescues hearing in a mouse model of Usher syndrome 3A and transduces hair cells in a non-human primate","volume":"13","author":"Gy\u00f6rgy","year":"2019","journal-title":"Mol. Ther., Methods Clin. Dev."},{"key":"10.1016\/j.mam.2025.101424_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2017.00521","article-title":"A novel retinal ganglion cell promoter for utility in AAV vectors","volume":"11","author":"Hanlon","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.mam.2025.101424_bib78","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1089\/hum.2008.107","article-title":"Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial","volume":"19","author":"Hauswirth","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.mam.2025.101424_bib79","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/iovs.66.1.6","article-title":"A penetrable AAV2 capsid variant for efficient intravitreal gene delivery to the retina","volume":"66","author":"He","year":"2025","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2025.101424_bib80","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/gt.2017.85","article-title":"Tropism of engineered and evolved recombinant AAV serotypes in the rd1 mouse and ex vivo primate retina","volume":"24","author":"Hickey","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.mam.2025.101424_bib81","doi-asserted-by":"crossref","DOI":"10.1089\/hum.2024.252","article-title":"A comprehensive review of clinically applied adeno-associated virus-based gene therapies for ocular disease","author":"Hinsch","year":"2025","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.mam.2025.101424_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120415","article-title":"M\u00fcller Glia activation in response to inherited retinal degeneration is highly varied and disease-specific","volume":"10","author":"Hippert","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2025.101424_bib83","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.omtm.2020.03.003","article-title":"Empowering retinal gene therapy with a specific promoter for human rod and cone ON-Bipolar cells","volume":"17","author":"Hulliger","year":"2020","journal-title":"Mol. Ther., Methods Clin. Dev."},{"key":"10.1016\/j.mam.2025.101424_bib84","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1038\/s41467-023-38038-y","article-title":"Mini-PCDH15 gene therapy rescues hearing in a mouse model of Usher syndrome type 1F","volume":"14","author":"Ivanchenko","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2025.101424_bib85","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41551-021-00788-9","article-title":"Application of prime editing to the correction of mutations and phenotypes in adult mice with liver and eye diseases","volume":"6","author":"Jang","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.mam.2025.101424_bib86","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1093\/hmg\/ddac013","article-title":"Multiomics analyses reveal early metabolic imbalance and mitochondrial stress in neonatal photoreceptors leading to cell death in Pde6brd1\/rd1 mouse model of retinal degeneration","volume":"31","author":"Jiang","year":"2022","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mam.2025.101424_bib87","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.omtn.2022.11.021","article-title":"Visual function restoration in a mouse model of Leber congenital amaurosis via therapeutic base editing","volume":"31","author":"Jo","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.mam.2025.101424_bib88","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev-genet-111523-102000","article-title":"M\u00fcller glial cell\u2013dependent regeneration of the retina in zebrafish and mice","volume":"58","author":"Jui","year":"2024","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.mam.2025.101424_bib89","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/s41593-019-0431-2","article-title":"Targeting neuronal and glial cell types with synthetic promoter AAVs in mice, non-human primates and humans","volume":"22","author":"J\u00fcttner","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.mam.2025.101424_bib90","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41592-019-0323-0","article-title":"In vivo RNA editing of point mutations via RNA-guided adenosine deaminases","volume":"16","author":"Katrekar","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.mam.2025.101424_bib91","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/s41587-021-01171-4","article-title":"Efficient in vitro and in vivo RNA editing via recruitment of endogenous ADARs using circular guide RNAs","volume":"40","author":"Katrekar","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.mam.2025.101424_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/99ee1789-a658-4fb0-8593-40a40e9f344a","article-title":"Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors","volume":"8","author":"Kay","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2025.101424_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.09.003","article-title":"Optogenetic targeting of AII amacrine cells restores retinal computations performed by the inner retina","volume":"31","author":"Khabou","year":"2023","journal-title":"Mol. Ther., Methods Clin. Dev."},{"key":"10.1016\/j.mam.2025.101424_bib94","doi-asserted-by":"crossref","first-page":"e7467","DOI":"10.1371\/journal.pone.0007467","article-title":"A novel adeno-associated viral variant for efficient and selective intravitreal transduction of rat m\u00fcller cells","volume":"4","author":"Klimczak","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2025.101424_bib95","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/gt.2008.32","article-title":"Targeting gene expression to cones with human cone opsin promoters in recombinant AAV","volume":"15","author":"Kom\u00e1romy","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.mam.2025.101424_bib96","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.mam.2025.101424_bib97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071363","article-title":"Rapid cohort generation and analysis of disease spectrum of large animal model of cone dystrophy","volume":"8","author":"Kostic","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2025.101424_bib98","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1080\/14712598.2022.2121646","article-title":"Advancements in ocular gene therapy delivery: vectors and subretinal, intravitreal, and suprachoroidal techniques","volume":"22","author":"Kovacs","year":"2022","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.mam.2025.101424_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-022-04016-1","article-title":"Bipolar cell targeted optogenetic gene therapy restores parallel retinal signaling and high-level vision in the degenerated retina","volume":"5","author":"Kralik","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.mam.2025.101424_bib100","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/bs.ctdb.2023.09.003","article-title":"Patient stem cell-derived in vitro disease models for developing novel therapies of retinal ciliopathies","volume":"155","author":"Kruczek","year":"2023","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.mam.2025.101424_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2024.101248","article-title":"Pluripotent stem cell-derived models of retinal disease: elucidating pathogenesis, evaluating novel treatments, and estimating toxicity","volume":"100","author":"Kurzawa-Akanbi","year":"2024","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.mam.2025.101424_bib102","doi-asserted-by":"crossref","first-page":"7438","DOI":"10.1038\/s41467-024-51575-4","article-title":"Interim safety and efficacy of gene therapy for RLBP1-associated retinal dystrophy: a phase 1\/2 trial","volume":"15","author":"Kvanta","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2025.101424_bib103","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ajhg.2010.07.018","article-title":"Nonsense mutations in FAM161A cause RP28-Associated recessive retinitis pigmentosa","volume":"87","author":"Langmann","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mam.2025.101424_bib104","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/jgm.1126","article-title":"Novel AAV serotypes for improved ocular gene transfer","volume":"10","author":"Lebherz","year":"2008","journal-title":"J. Gene Med."},{"key":"10.1016\/j.mam.2025.101424_bib105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020881","article-title":"Adeno-associated viral vector-mediated transgene expression is independent of DNA methylation in primate liver and skeletal muscle","volume":"6","author":"L\u00e9ger","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2025.101424_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116148","article-title":"Novel chemical tyrosine functionalization of adeno-associated virus improves gene transfer efficiency in liver and retina","volume":"171","author":"Leray","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mam.2025.101424_bib107","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000526317","article-title":"Gene therapy for inherited retinal disease: long-term durability of effect","volume":"66","author":"Leroy","year":"2023","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.mam.2025.101424_bib108","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.visres.2007.07.026","article-title":"Cone-specific expression using a human red opsin promoter in recombinant AAV","volume":"48","author":"Li","year":"2008","journal-title":"Vis. Res."},{"key":"10.1016\/j.mam.2025.101424_bib109","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1006\/mthe.2001.0473","article-title":"Long-term protection of retinal structure but not function using rAAV.CNTF in animal models of retinitis pigmentosa","volume":"4","author":"Liang","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mam.2025.101424_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101674","article-title":"Identification of cis-regulatory modules for adeno-associated virus-based cell-type-specific targeting in the retina and brain","volume":"298","author":"Lin","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mam.2025.101424_bib111","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.84065","article-title":"Allele-specific gene-editing approach for vision loss restoration in RHO-associated retinitis pigmentosa","volume":"12","author":"Liu","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.mam.2025.101424_bib112","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/gt.2016.42","article-title":"AAV-Mediated transduction and targeting of retinal bipolar cells with improved mGluR6 promoters in rodents and primates","volume":"23","author":"Lu","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.mam.2025.101424_bib113","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41434-024-00485-7","article-title":"AAV dose-dependent transduction efficiency in retinal ganglion cells and functional efficacy of optogenetic vision restoration","volume":"31","author":"Lu","year":"2024","journal-title":"Gene Ther."},{"key":"10.1016\/j.mam.2025.101424_bib114","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1038\/s41467-024-48221-4","article-title":"An adeno-associated virus variant enabling efficient ocular-directed gene delivery across species","volume":"15","author":"Luo","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2025.101424_bib115","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ymthe.2017.11.019","article-title":"Triple vectors expand AAV transfer capacity in the retina","volume":"26","author":"Maddalena","year":"2018","journal-title":"Mol. Ther."},{"issue":"25","key":"10.1016\/j.mam.2025.101424_bib116","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","article-title":"Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10","volume":"252","author":"Maeder","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.mam.2025.101424_bib117","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.ophtha.2021.03.031","article-title":"Durability of voretigene neparvovec for biallelic RPE65-Mediated inherited retinal disease: phase 3 results at 3 and 4 years","volume":"128","author":"Maguire","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.mam.2025.101424_bib118","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.ophtha.2019.06.017","article-title":"Efficacy, safety, and durability of voretigene neparvovec-rzyl in RPE65 mutation\u2013associated inherited retinal dystrophy: results of phase 1 and 3 trials","volume":"126","author":"Maguire","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.mam.2025.101424_bib119","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","article-title":"Safety and efficacy of gene transfer for Leber's congenital amaurosis","volume":"358","author":"Maguire","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mam.2025.101424_bib120","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1089\/hum.2013.154","article-title":"Combined rod and cone transduction by adeno-associated virus 2\/8","volume":"24","author":"Manfredi","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.mam.2025.101424_bib121","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev-vision-102016-061338","article-title":"The transduction Cascade in retinal ON-Bipolar cells: signal processing and disease","volume":"3","author":"Martemyanov","year":"2017","journal-title":"Annu. Rev. Vis. Sci."},{"key":"10.1016\/j.mam.2025.101424_bib122","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1016\/j.ymthe.2023.08.011","article-title":"Gene augmentation therapy attenuates retinal degeneration in a knockout mouse model of Fam161a retinitis pigmentosa","volume":"31","author":"Matsevich","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mam.2025.101424_bib123","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1167\/tvst.9.7.20","article-title":"Assessment of AAV dual vector safety in the Abca4\u2212\/\u2212 mouse model of Stargardt disease","volume":"9","author":"McClements","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.mam.2025.101424_bib124","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s40291-024-00722-0","article-title":"Gene therapies in clinical development to treat retinal disorders","volume":"28","author":"McClements","year":"2024","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.mam.2025.101424_bib125","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.570909","article-title":"Optogenetic gene therapy for the degenerate retina: recent advances","volume":"14","author":"McClements","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.mam.2025.101424_bib126","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.3390\/ijms25052887","article-title":"Retinal ciliopathies and potential gene therapies: a focus on human iPSC-Derived organoid models","volume":"25","author":"McDonald","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2025.101424_bib127","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1093\/hmg\/ddg232","article-title":"CRB1 is essential for external limiting membrane integrity and photoreceptor morphogenesis in the mammalian retina","volume":"12","author":"Mehalow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mam.2025.101424_bib128","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001649","article-title":"The connecting cilium inner scaffold provides a structural foundation that protects against retinal degeneration","volume":"20","author":"Mercey","year":"2022","journal-title":"PLoS Biol."},{"key":"10.1016\/j.mam.2025.101424_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101187","article-title":"Mannose-coupled AAV2: a second-generation AAV vector for increased retinal gene therapy efficiency","volume":"32","author":"M\u00e9vel","year":"2024","journal-title":"Mol. Ther., Methods Clin. Dev."},{"key":"10.1016\/j.mam.2025.101424_bib130","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41433-024-03149-3","article-title":"Robotising vitreoretinal surgeries","volume":"39","author":"Mi","year":"2024","journal-title":"Eye"},{"key":"10.1016\/j.mam.2025.101424_bib131","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3390\/v13010101","article-title":"Completion of the AAV structural atlas: serotype capsid structures reveals clade-specific features","volume":"13","author":"Mietzsch","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.mam.2025.101424_bib132","doi-asserted-by":"crossref","first-page":"16515","DOI":"10.1038\/s41598-020-73257-z","article-title":"Novel 199 base pair NEFH promoter drives expression in retinal ganglion cells","volume":"10","author":"Millington-Ward","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mam.2025.101424_bib133","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.3390\/ijms24043847","article-title":"RPE-directed gene therapy improves mitochondrial function in murine dry AMD models","volume":"24","author":"Millington-Ward","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2025.101424_bib134","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2117038119","article-title":"Targeting ON-bipolar cells by AAV gene therapy stably reverses LRIT3-congenital stationary night blindness","volume":"119","author":"Miyadera","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mam.2025.101424_bib135","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.ymthe.2018.04.017","article-title":"In situ gene therapy via AAV-CRISPR-Cas9-Mediated targeted gene regulation","volume":"26","author":"Moreno","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mam.2025.101424_bib136","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S1474-4422(17)30161-8","article-title":"Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study","volume":"16","author":"Moss","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.mam.2025.101424_bib137","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41591-024-03422-8","article-title":"High-efficiency base editing in the retina in primates and human tissues","volume":"31","author":"Muller","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.mam.2025.101424_bib138","doi-asserted-by":"crossref","first-page":"6362","DOI":"10.1167\/iovs.15-16400","article-title":"Allele-specific inhibition of rhodopsin with an antisense oligonucleotide slows photoreceptor cell degeneration","volume":"56","author":"Murray","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2025.101424_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2024.101289","article-title":"Genetic therapies and potential therapeutic applications of CRISPR activators in the eye","volume":"102","author":"Ng","year":"2024","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.mam.2025.101424_bib140","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41434-022-00380-z","article-title":"Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cells: comparison of five promoters","volume":"30","author":"Nieuwenhuis","year":"2023","journal-title":"Gene Ther."},{"key":"10.1016\/j.mam.2025.101424_bib141","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1038\/s41467-021-25204-3","article-title":"Mirtron-mediated RNA knockdown\/replacement therapy for the treatment of dominant retinitis pigmentosa","volume":"12","author":"Orlans","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2025.101424_bib142","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.64175","article-title":"Scaavengr, a transcriptome-based pipeline for quantitative ranking of engineered AAVs with single-cell resolution","volume":"10","author":"\u00d6zt\u00fcrk","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.mam.2025.101424_bib143","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1089\/hum.2011.142","article-title":"Efficacy of codelivery of dual AAV2\/5 vectors in the murine retina and hippocampus","volume":"23","author":"Palfi","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.mam.2025.101424_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cels.2019.10.003","article-title":"CRISPR-based synthetic transcription factors in vivo: the future of therapeutic cellular programming","volume":"10","author":"Pandelakis","year":"2020","journal-title":"Cell Syst."},{"key":"10.1016\/j.mam.2025.101424_bib145","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ajhg.2021.01.006","article-title":"Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model","volume":"108","author":"Patrizi","year":"2021","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mam.2025.101424_bib146","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013392","article-title":"Novel AAV capsids for intravitreal gene therapy of photoreceptor disorders","volume":"13","author":"Pavlou","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.mam.2025.101424_bib147","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/gt.2015.93","article-title":"Photoreceptor rescue by an abbreviated human RPGR gene in a murine model of X-linked retinitis pigmentosa","volume":"23","author":"Pawlyk","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.mam.2025.101424_bib148","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1093\/hmg\/ddv062","article-title":"Gene therapy into photoreceptors and M\u00fcller glial cells restores retinal structure and function in CRB1 retinitis pigmentosa mouse models","volume":"24","author":"Pellissier","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mam.2025.101424_bib149","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1172\/JCI95161","article-title":"Patients and animal models of CNG\u03b21-deficient retinitis pigmentosa support gene augmentation approach","volume":"128","author":"Petersen-Jones","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.mam.2025.101424_bib150","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/mt.2010.234","article-title":"Novel properties of tyrosine-mutant AAV2 vectors in the mouse retina","volume":"19","author":"Petrs-Silva","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mam.2025.101424_bib151","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/mt.2008.269","article-title":"High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors","volume":"17","author":"Petrs-Silva","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mam.2025.101424_bib152","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa2309915","article-title":"Gene editing for CEP290 -Associated retinal degeneration","volume":"390","author":"Pierce","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mam.2025.101424_bib153","doi-asserted-by":"crossref","first-page":"8562","DOI":"10.1167\/iovs.10-6835","article-title":"Hypoxia-regulated retinal glial cell\u2013specific promoter for potential gene therapy in disease","volume":"52","author":"Prentice","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2025.101424_bib154","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1016\/j.ymthe.2023.10.017","article-title":"Dual AAV-based PCDH15 gene therapy achieves sustained rescue of visual function in a mouse model of Usher syndrome 1F","volume":"31","author":"Riaz","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mam.2025.101424_bib155","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.1038\/s41467-023-42386-0","article-title":"mRNA trans-splicing dual AAV vectors for (epi)genome editing and gene therapy","volume":"14","author":"Riedmayr","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2025.101424_bib156","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.ymthe.2025.01.030","article-title":"Enhanced restoration of visual code after targeting ON bipolar cells compared with retinal ganglion cells with optogenetic therapy","volume":"33","author":"Rodgers","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mam.2025.101424_bib157","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.4103\/1673-5374.306063","article-title":"The future of retinal gene therapy: evolving from subretinal to intravitreal vector delivery","volume":"16","author":"Ross","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.mam.2025.101424_bib158","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/s41591-022-01755-w","article-title":"Intravitreal antisense oligonucleotide sepofarsen in Leber congenital amaurosis type 10: a phase 1b\/2 trial","volume":"28","author":"Russell","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.mam.2025.101424_bib159","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/s41591-021-01351-4","article-title":"Partial recovery of visual function in a blind patient after optogenetic therapy","volume":"27","author":"Sahel","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.mam.2025.101424_bib160","doi-asserted-by":"crossref","first-page":"14207","DOI":"10.3390\/ijms241814207","article-title":"Selective block of upregulated Kv1.3 potassium channels in ON-Bipolar cells of the blind retina enhances optogenetically restored signaling","volume":"24","author":"Schilardi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2025.101424_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102130","article-title":"A pipeline for identifying guide RNA sequences that promote RNA editing of nonsense mutations that cause inherited retinal diseases","volume":"35","author":"Schneider","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.mam.2025.101424_bib162","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.15252\/emmm.201505699","article-title":"Red\u2010shifted channelrhodopsin stimulation restores light responses in blind mice, macaque retina, and human retina","volume":"8","author":"Sengupta","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.mam.2025.101424_bib163","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1167\/iovs.13-11673","article-title":"Subretinal gene therapy of mice with Bardet-Biedl syndrome type 1","volume":"54","author":"Seo","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2025.101424_bib164","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1089\/hum.2018.118","article-title":"New MiniPromoter Ple345 (NEFL) drives strong and specific expression in retinal ganglion cells of mouse and primate retina","volume":"30","author":"Simpson","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.mam.2025.101424_bib165","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.ymthe.2018.03.015","article-title":"Amelioration of neurosensory structure and function in animal and cellular models of a congenital blindness","volume":"26","author":"Song","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mam.2025.101424_bib166","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2015.00494","article-title":"A survey of retinal remodeling","volume":"9","author":"Strettoi","year":"2015","journal-title":"Front. Cell. Neurosci."},{"issue":"7","key":"10.1016\/j.mam.2025.101424_bib167","first-page":"1","article-title":"Involvement of innate immune system in late stages of inherited photoreceptor degeneration","volume":"71","author":"Sudharsan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mam.2025.101424_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2025.05.020","article-title":"Novel photoreceptor-specific promoters for gene therapy in mid- to late-stage retinal degeneration","author":"Sudharsan","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mam.2025.101424_bib169","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/hum.2023.201","article-title":"Knockout and replacement gene surgery to treat rhodopsin-mediated autosomal dominant retinitis pigmentosa","volume":"35","author":"Sun","year":"2024","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.mam.2025.101424_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.visres.2023.108260","article-title":"Extended functional rescue following AAV gene therapy in a canine model of LRIT3-congenital stationary night blindness","volume":"209","author":"Takahashi","year":"2023","journal-title":"Vis. Res."},{"key":"10.1016\/j.mam.2025.101424_bib171","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1038\/s41467-022-29550-8","article-title":"Therapeutic homology-independent targeted integration in retina and liver","volume":"13","author":"Tornabene","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2025.101424_bib172","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/hum.2019.220","article-title":"Can adeno-associated viral vectors deliver effectively large genes?","volume":"31","author":"Tornabene","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.mam.2025.101424_bib173","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.omtm.2021.10.004","article-title":"Inclusion of a degron reduces levels of undesired inteins after AAV-mediated protein trans-splicing in the retina","volume":"23","author":"Tornabene","year":"2021","journal-title":"Mol. Ther., Methods Clin. Dev."},{"key":"10.1016\/j.mam.2025.101424_bib174","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav4523","article-title":"Intein-mediated protein trans-splicing expands adeno-associated virus transfer capacity in the retina","volume":"11","author":"Tornabene","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.mam.2025.101424_bib175","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/emmm.201302948","article-title":"Effective delivery of large genes to the retina by dual AAV vectors","volume":"6","author":"Trapani","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.mam.2025.101424_bib176","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1093\/hmg\/ddv386","article-title":"Improved dual AAV vectors with reduced expression of truncated proteins are safe and effective in the retina of a mouse model of Stargardt disease","volume":"24","author":"Trapani","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mam.2025.101424_bib177","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.ophtha.2018.04.001","article-title":"Clustered regularly interspaced short palindromic repeats-based genome surgery for the treatment of autosomal dominant retinitis pigmentosa","volume":"125","author":"Tsai","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.mam.2025.101424_bib178","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002143","article-title":"Restoring the ON switch in blind retinas: Opto-mGluR6, a next-generation, cell-tailored optogenetic tool","volume":"13","author":"van Wyk","year":"2015","journal-title":"PLoS Biol."},{"key":"10.1016\/j.mam.2025.101424_bib179","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002103","article-title":"Dosage thresholds for AAV2 and AAV8 photoreceptor gene therapy in monkey","volume":"3","author":"Vandenberghe","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.mam.2025.101424_bib180","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/78182","article-title":"Mutational hot spot within a new RPGR exon in X-linked retinitis pigmentosa","volume":"25","author":"Vervoort","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mam.2025.101424_bib181","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mam.2025.101424_bib182","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang","year":"2024","journal-title":"Nat. Signal Transduct. Target. Ther."},{"key":"10.1016\/j.mam.2025.101424_bib183","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adn7540","article-title":"dCasMINI-mediated therapy rescues photoreceptors degeneration in a mouse model of retinitis pigmentosa","volume":"10","author":"Wang","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mam.2025.101424_bib184","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0896-6273(92)90181-C","article-title":"A locus control region adjacent to the human red and green visual pigment genes","volume":"9","author":"Wang","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.mam.2025.101424_bib185","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41536-021-00177-5","article-title":"Development of an optogenetic gene sensitive to daylight and its implications in vision restoration","volume":"6","author":"Watanabe","year":"2021","journal-title":"NPJ Regen. Med."},{"key":"10.1016\/j.mam.2025.101424_bib186","doi-asserted-by":"crossref","first-page":"21946","DOI":"10.1038\/s41598-023-49112-2","article-title":"AAV capsid bioengineering in primary human retina models","volume":"13","author":"Westhaus","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mam.2025.101424_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2022.101153","article-title":"Cellular and subcellular optogenetic approaches towards neuroprotection and vision restoration","volume":"96","author":"Wood","year":"2023","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.mam.2025.101424_bib188","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.145029","article-title":"Nrf 2 overexpression rescues the RPE in mouse models of retinitis pigmentosa","volume":"6","author":"Wu","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.mam.2025.101424_bib189","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.ymthe.2022.02.010","article-title":"CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa","volume":"30","author":"Wu","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mam.2025.101424_bib190","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1038\/s41467-023-40655-6","article-title":"AAV-mediated base-editing therapy ameliorates the disease phenotypes in a mouse model of retinitis pigmentosa","volume":"14","author":"Wu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2025.101424_bib191","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1073\/pnas.1821000116","article-title":"AAV cis-regulatory sequences are correlated with ocular toxicity","volume":"116","author":"Xiong","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mam.2025.101424_bib192","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1016\/j.molcel.2021.08.008","article-title":"Engineered miniature CRISPR-cas system for mammalian genome regulation and editing","volume":"81","author":"Xu","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.mam.2025.101424_bib193","doi-asserted-by":"crossref","DOI":"10.1016\/j.visres.2023.108192","article-title":"Genome editing, a superior therapy for inherited retinal diseases","volume":"206","author":"Yan","year":"2023","journal-title":"Vis. Res."},{"key":"10.1016\/j.mam.2025.101424_bib194","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41587-021-01180-3","article-title":"Engineered circular ADAR-recruiting RNAs increase the efficiency and fidelity of RNA editing in vitro and in vivo","volume":"40","author":"Yi","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.mam.2025.101424_bib195","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s13059-023-03086-6","article-title":"Utilizing AAV-mediated LEAPER 2.0 for programmable RNA editing in non-human primates and nonsense mutation correction in humanized Hurler syndrome mice","volume":"24","author":"Yi","year":"2023","journal-title":"Genome Biol."},{"key":"10.1016\/j.mam.2025.101424_bib196","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1001\/jamaophthalmol.2024.5375","article-title":"Five-year outcomes of lenadogene nolparvovec gene therapy in leber hereditary optic neuropathy","volume":"143","author":"Yu-Wai-Man","year":"2025","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.mam.2025.101424_bib197","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1073\/pnas.1119577109","article-title":"Gene delivery to mitochondria by targeting modified adenoassociated virus suppresses Leber's hereditary optic neuropathy in a mouse model","volume":"109","author":"Yu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mam.2025.101424_bib198","article-title":"Retinal transduction profiling of diverse AAV serotypes via intravitreal injection","author":"Zhang","year":"2025","journal-title":"J. Virol."},{"key":"10.1016\/j.mam.2025.101424_bib199","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1089\/hum.2017.049","article-title":"Gene therapy using a miniCEP290 fragment delays photoreceptor degeneration in a mouse model of leber congenital amaurosis","volume":"29","author":"Zhang","year":"2018","journal-title":"Hum. Gene Ther."}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299725000883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299725000883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:58:01Z","timestamp":1777478281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299725000883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":200,"alternative-id":["S0098299725000883"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2025.101424","relation":{},"ISSN":["0098-2997"],"issn-type":[{"value":"0098-2997","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precision gene therapy: Tailoring rAAV-mediated gene therapies for inherited retinal dystrophies (IRDs)","name":"articletitle","label":"Article Title"},{"value":"Molecular Aspects of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mam.2025.101424","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101424"}}